Literature DB >> 31841252

2004 chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians: a comparative study.

Subash S Heraganahally1,2,3,4, Sanjiwika L Wasgewatta1, Kelly McNamara1,2,3, Joy J Mingi4,5, Sumit Mehra1,6, Carla C Eisemberg7, Graeme Maguire8,9,10.   

Abstract

BACKGROUND: Chronic respiratory disorders are highly prevalent in Aboriginal Australian population, including chronic obstructive pulmonary disease (COPD) and bronchiectasis. However, there is paucity of information in the literature among Aboriginal patients with underlying COPD with and without bronchiectasis. AIMS: In this retrospective study we evaluated the demographic and clinical characteristics of adult Aboriginal Australian patients with a clinical diagnosis of COPD with and without bronchiectasis from the remote communities of the Northern Territory of Australia.
METHODS: Clinical records were reviewed to extract information on demographics, respiratory and medical comorbid conditions, COPD directed treatment, hospital admission frequency and exacerbations. Chest radiology were reviewed to evaluate the presence or absence of bronchiectasis. Spirometry results, sputum culture and cardiac investigations were also recorded.
RESULTS: Of the 767 patients assessed in the remote community respiratory outreach clinics 380 (49%) patients had a clinical diagnosis of COPD. Chest X-ray and computed tomography scan were available to evaluate the presence of bronchiectasis in 258 patients. Of the 258/380 patients, 176/258 (68.2%) were diagnosed to have COPD alone and 82/258 (31.8%) had bronchiectasis along with COPD. The mean age was 56 and 59 years among patients with and without bronchiectasis, respectively, and 57% were males with bronchiectasis. Patients with bronchiectasis had lower body mass index (22 vs 24 kg/m2 ), frequent hospital admissions (2.0 vs 1.5/year) and productive cough (32.1% vs 28.9%). Spirometry showed 77% had forced expiratory volume in 1 s (FEV1 )/forced vital capacity ratio <0.7. In 81% and 75% of patients with and without bronchiectasis the FEV1 /forced vital capacity ratio was <0.7 and the mean FEV1 was 39% and 43% respectively.
CONCLUSIONS: About 32% of Aboriginal Australians had co-existent bronchiectasis with COPD. Lower body mass index, productive cough, frequent hospital admission and marginally more severe reduction in lung function were noted among patients with COPD and bronchiectasis compared to those with COPD in isolation.
© 2019 Royal Australasian College of Physicians.

Entities:  

Keywords:  Aboriginal; Indigenous; bronchiectasis; chronic obstructive pulmonary disease; spirometry

Mesh:

Year:  2020        PMID: 31841252     DOI: 10.1111/imj.14718

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  10 in total

1.  Gender Differences in the Clinical and Polysomnographic Characteristics Among Australian Aboriginal Patients with Obstructive Sleep Apnea.

Authors:  Sumit Mehra; Ram H Ghimire; Joy J Mingi; Monica Hatch; Himanshu Garg; Robert Adams; Subash S Heraganahally
Journal:  Nat Sci Sleep       Date:  2020-08-24

Review 2.  Pulmonary function testing in COPD: looking beyond the curtain of FEV1.

Authors:  Sotirios Kakavas; Ourania S Kotsiou; Fotis Perlikos; Maria Mermiri; Georgios Mavrovounis; Konstantinos Gourgoulianis; Ioannis Pantazopoulos
Journal:  NPJ Prim Care Respir Med       Date:  2021-05-07       Impact factor: 2.871

3.  The Top End Sleepiness Scale (TESS): A New Tool to Assess Subjective Daytime Sleepiness Among Indigenous Australian Adults.

Authors:  Edmund Benn; Hugh Wirth; Teagan Short; Timothy Howarth; Subash S Heraganahally
Journal:  Nat Sci Sleep       Date:  2021-03-04

4.  Comparison of diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) between Indigenous Australians and Australian Caucasian adults.

Authors:  Timothy Howarth; Helmi Ben Saad; Ara J Perez; Charmain B Atos; Elisha White; Subash S Heraganahally
Journal:  PLoS One       Date:  2021-04-02       Impact factor: 3.240

5.  The Effects of Inhaled Airway Directed Pharmacotherapy on Decline in Lung Function Parameters Among Indigenous Australian Adults With and Without Underlying Airway Disease.

Authors:  Subash S Heraganahally; Tarun R Ponneri; Timothy P Howarth; Helmi Ben Saad
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-09-29

6.  Sex differences in pulmonary function parameters among Indigenous Australians with and without chronic airway disease.

Authors:  Subash S Heraganahally; Timothy Howarth; Lisa Sorger; Helmi Ben Saad
Journal:  PLoS One       Date:  2022-02-08       Impact factor: 3.240

7.  Differences in the Spirometry Parameters Between Indigenous and Non-Indigenous Patients with COPD: A Matched Control Study.

Authors:  Dorothy F L Sze; Timothy P Howarth; Clair D Lake; Helmi Ben Saad; Subash S Heraganahally
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-04-21

8.  COPD disease knowledge, self-awareness and reasons for hospital presentations among a predominately Indigenous Australian cohort: a study to explore preventable hospitalisation.

Authors:  Arijeet Pal; Timothy P Howarth; Chris Rissel; Raelene Messenger; Siji Issac; Linda Ford; Christine Connors; Subash Heraganahally
Journal:  BMJ Open Respir Res       Date:  2022-08

9.  The Prevalence of Bronchodilator Responsiveness "Asthma" Among Adult Indigenous Australians Referred for Lung Function Testing in the Top End Northern Territory of Australia.

Authors:  Subash S Heraganahally; Timothy P Howarth; Angus Lloyd; Elisha White; Antony Veale; Helmi Ben Saad
Journal:  J Asthma Allergy       Date:  2022-09-14

10.  Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study.

Authors:  Subash Heraganahally; Timothy P Howarth; Elisha White; Helmi Ben Saad
Journal:  BMJ Open Respir Res       Date:  2021-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.